Sectors > Top Reports > Selecta Memo 250320

Selecta Memo 250320

Selecta Hits Rock Bottom? Conviction Buy On SSNs at c. 50 Cents
PUBLISHED: 25 March 2020
PAGES: 276
SUBMARKET: Selecta, Top Reports, Top Reports,


Why Read?

  • Understand our new base, bear and bull case projections (including for liquidity) in the new coronavirus world of lockdowns and significant disruption to both Selecta’s workplace and on-the-go points of sale
  • Understand why Selecta, trading at just over 3x Q4 19 LTM EBITDA and on a similar multiple vs FY 21E EBITDA, represents a deep value opportunity outright and compared to Italian competitor, IVS
  • Analysis of refinancing vs restructuring / liability management exercise scenarios and associated probabilities
  • Recovery rate analysis on Selecta’s Senior Secured Notes (SSNs) across base, bear and bull scenarios
  • Business analysis – segments, regions, clients, suppliers, substitutes
  • Industry overview – drivers; main private and public competitors; regulation
  • Pelican Rouge, Argenta Group and Express Vending acquisition analysis
  • Understand EBITDA potential with the expected synergies and one-off costs
  • Liquidity analysis and remaining liquidity levers
  • Understand the capital structure and the key terms of each instrument
  • Detailed DCF and trading comparables valuations

What’s New?

  • Coronavirus (COVID-19) impact on Selecta. Updated financial projections including for liquidity across base, bear and bull cases
  • Comparison of Selecta vs Italian competitor, IVS

Questions Answered

  • What is the potential impact of COVID-19 on the business, both in the short and long term?
  • Under what circumstances would liquidity break and which additional liquidity levers remain?
  • Will the business be able to deleverage post the coronavirus disruption to the extent needed to refinance?
  • What recovery can be expected on the Senior Secured Notes (SSNs)?


Connect with us